Literature DB >> 9696813

Rescue of defective poliovirus RNA replication by 3AB-containing precursor polyproteins.

J S Towner1, M M Mazanet, B L Semler.   

Abstract

This study demonstrates the in vitro complementation of an RNA replication-defective lesion in poliovirus RNA by providing a replicase/polymerase precursor polypeptide [P3(wt) (wild type)] in trans. The replication-defective mutation was a phenylalanine-to-histidine change (F69H) in the hydrophobic domain of the membrane-associated viral protein 3AB. RNAs encoding wild-type forms of protein 3AB or the P3 precursor polypeptide were cotranslated with full-length poliovirus RNAs containing the F69H mutation in a HeLa cell-free translation/replication assay in an attempt to trans complement the RNA replication defect exhibited by the 3AB(F69H) lesion. Unexpectedly, generation of 3AB(wt) in trans was not able to efficiently complement the defective replication complex; however, cotranslation of the large P3(wt) precursor protein allowed rescue of RNA replication. Furthermore, P3 proteins harboring mutations that resulted in either an inactive polymerase or an inactive proteinase domain displayed differential abilities to trans complement the RNA replication defect. Our results indicate that replication proteins like 3AB may need to be delivered to the poliovirus replication complex in the form of a larger 3AB-containing protein precursor prior to complex assembly rather than as the mature viral cleavage product.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696813      PMCID: PMC109941     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells.

Authors:  P S Collis; B J O'Donnell; D J Barton; J A Rogers; J B Flanegan
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Determinants of membrane association for poliovirus protein 3AB.

Authors:  J S Towner; T V Ho; B L Semler
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

3.  Amino terminal regions of poliovirus 2C protein mediate membrane binding.

Authors:  A C Echeverri; A Dasgupta
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

4.  RNA-protein interactions directed by the 3' end of human rhinovirus genomic RNA.

Authors:  S Todd; J H Nguyen; B L Semler
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

5.  Interaction between the 5'-terminal cloverleaf and 3AB/3CDpro of poliovirus is essential for RNA replication.

Authors:  W Xiang; K S Harris; L Alexander; E Wimmer
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

6.  Intragenomic complementation of a 3AB mutant in dicistronic polioviruses.

Authors:  X Cao; E Wimmer
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

7.  Coupling between genome translation and replication in an RNA virus.

Authors:  J E Novak; K Kirkegaard
Journal:  Genes Dev       Date:  1994-07-15       Impact factor: 11.361

8.  Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3Dpol.

Authors:  S J Plotch; O Palant
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations.

Authors:  N L Teterina; W D Zhou; M W Cho; E Ehrenfeld
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

10.  Complete replication of poliovirus in vitro: preinitiation RNA replication complexes require soluble cellular factors for the synthesis of VPg-linked RNA.

Authors:  D J Barton; E P Black; J B Flanegan
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  37 in total

1.  Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis.

Authors:  J Herold; R Andino
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Initiation of poliovirus negative-strand RNA synthesis requires precursor forms of p2 proteins.

Authors:  Christy Jurgens; James B Flanegan
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Recombination of poliovirus RNA proceeds in mixed replication complexes originating from distinct replication start sites.

Authors:  Denise Egger; Kurt Bienz
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Intracellular topology and epitope shielding of poliovirus 3A protein.

Authors:  Sunny S Choe; Karla Kirkegaard
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 5.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  Strand-specific RNA synthesis defects in a poliovirus with a mutation in protein 3A.

Authors:  Natalya L Teterina; Mario S Rinaudo; Ellie Ehrenfeld
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

7.  Improving proteolytic cleavage at the 3A/3B site of the hepatitis A virus polyprotein impairs processing and particle formation, and the impairment can be complemented in trans by 3AB and 3ABC.

Authors:  Y Kusov; V Gauss-Müller
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Role of RNA structure and RNA binding activity of foot-and-mouth disease virus 3C protein in VPg uridylylation and virus replication.

Authors:  Arabinda Nayak; Ian G Goodfellow; Kathryn E Woolaway; James Birtley; Stephen Curry; Graham J Belsham
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

9.  The poly(A) binding protein is internalized in virus-induced vesicles or redistributed to the nucleolus during turnip mosaic virus infection.

Authors:  Chantal Beauchemin; Jean-François Laliberté
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

10.  Functional interaction of heterogeneous nuclear ribonucleoprotein C with poliovirus RNA synthesis initiation complexes.

Authors:  Jo Ellen Brunner; Joseph H C Nguyen; Holger H Roehl; Tri V Ho; Kristine M Swiderek; Bert L Semler
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.